FDA Inspection 1320422 — Prof. Tomasz Wrobel MD, PhD
The FDA completed an inspection of Prof. Tomasz Wrobel MD, PhD on April 28, 2026 in Wroclaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 28, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wroclaw (Poland)
Additional Details
Clinical Investigator (CI)